BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 855 filers reported holding BAXTER INTL INC in Q3 2013. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $173,000 | -9.4% | 2,227 | 0.0% | 0.02% | -6.2% |
| Q4 2021 | $191,000 | +11.7% | 2,227 | +4.9% | 0.02% | +6.7% |
| Q3 2021 | $171,000 | 0.0% | 2,122 | 0.0% | 0.02% | -6.2% |
| Q2 2021 | $171,000 | +64.4% | 2,122 | +71.7% | 0.02% | +60.0% |
| Q1 2021 | $104,000 | +5.1% | 1,236 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $99,000 | +19.3% | 1,236 | +19.3% | 0.01% | +10.0% |
| Q3 2020 | $83,000 | -15.3% | 1,036 | -8.8% | 0.01% | -28.6% |
| Q2 2020 | $98,000 | -5.8% | 1,136 | -11.0% | 0.01% | -22.2% |
| Q1 2020 | $104,000 | -9.6% | 1,276 | -7.3% | 0.02% | +5.9% |
| Q4 2019 | $115,000 | -12.2% | 1,376 | -8.0% | 0.02% | -22.7% |
| Q3 2019 | $131,000 | +151.9% | 1,496 | +135.2% | 0.02% | +144.4% |
| Q2 2019 | $52,000 | 0.0% | 636 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $52,000 | +23.8% | 636 | 0.0% | 0.01% | +11.1% |
| Q4 2018 | $42,000 | -14.3% | 636 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $49,000 | +4.3% | 636 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $47,000 | +14.6% | 636 | 0.0% | 0.01% | +12.5% |
| Q1 2018 | $41,000 | 0.0% | 636 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $41,000 | +2.5% | 636 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $40,000 | +2.6% | 636 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $39,000 | +18.2% | 636 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $33,000 | +17.9% | 636 | 0.0% | 0.01% | +14.3% |
| Q4 2016 | $28,000 | -6.7% | 636 | 0.0% | 0.01% | -12.5% |
| Q3 2016 | $30,000 | +3.4% | 636 | 0.0% | 0.01% | +14.3% |
| Q2 2016 | $29,000 | +11.5% | 636 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $26,000 | +8.3% | 636 | 0.0% | 0.01% | +16.7% |
| Q4 2015 | $24,000 | +14.3% | 636 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $21,000 | -77.4% | 636 | -52.4% | 0.01% | -73.9% |
| Q2 2015 | $93,000 | -83.0% | 1,336 | -83.2% | 0.02% | -83.2% |
| Q1 2015 | $546,000 | +187.4% | 7,968 | +206.9% | 0.14% | +168.6% |
| Q4 2014 | $190,000 | +57.0% | 2,596 | +54.0% | 0.05% | +37.8% |
| Q3 2014 | $121,000 | -0.8% | 1,686 | 0.0% | 0.04% | 0.0% |
| Q2 2014 | $122,000 | +19.6% | 1,686 | +21.6% | 0.04% | +12.1% |
| Q1 2014 | $102,000 | +12.1% | 1,386 | 0.0% | 0.03% | -5.7% |
| Q3 2013 | $91,000 | -5.2% | 1,386 | 0.0% | 0.04% | -10.3% |
| Q2 2013 | $96,000 | – | 1,386 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |